360Dx Cancer Bulletin: Labs, Advocacy Groups Push Back on Medicare Policy Shift on NGS Testing for Hereditary Cancer Risk

Cancer Bulletin In-Depth Reporting From The 360Dx Newsroom

Organizational Access to GenomeWeb Premium  Did you know your email address could give you instant access to the industry's best life science journalism? It does if your company or institution has an organizational license to GenomeWeb Premium content! Register with your work email address or contact customerservice@360Dx.com to find out if you qualify! Recent Premium Articles   Labs, Advocacy Groups Push Back on Medicare Policy Shift on NGS Testing for Hereditary Cancer Risk Published on Jan 22, 2019   Liquid Biopsy Panel Expansion Enables Admera Health to Add Immunotherapy Prediction Published on Jan 18, 2019   BioFluidica Applying Liquid Biopsy to Detect Leukemia While Reducing Biopsies Published on Jan 17, 2019   Artificial Intelligence Outperforms Humans in Cervical Cancer Screening Published on Jan 17, 2019   Minimal Residual Disease Sequencing Poised to Grow Following Lag in Adoption Published on Jan 16, 2019 Recent Free Articles   23andMe Gets FDA OK for Genetic Risk Report on Hereditary Colorectal Cancer Syndrome Published on Jan 22, 2019   Sienna Diagnostics Inks New Distribution Deal for Bladder Cancer Test Published on Jan 22, 2019   Medicare Covers Adaptive Biotechnologies' ClonoSeq Assay Published on Jan 18, 2019   Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug Published on Jan 16, 2019 Evaluating the Agilent HCM Mastr Assay with Seraseq Cardiomyopathy Reference Material This white paper from SeraCare shows how the Seraseq Cardiomyopathy Reference Material is capable of rapid evaluation of the HCM MASTR assay, allowing for easy and rapid implementation of the assay. Download it from GenomeWeb's White Paper Channel. Recommended for You free   Accelerate Diagnostics Preliminary Q4 Revenues Down 14 Percent Published on Jan 07, 2019 free   Led by CareDx and Veracyte, 360Dx Index Sees Modest Gain in 2018 Published on Jan 02, 2019 Development of Reference Materials for NGS based Somatic Variant Detection and Fusion Detection in Myeloid Cancers  This Scientific Poster from SeraCare provides reference materials that may aid the development, optimization, and verification of NGS-based myeloid disease testing. Download it from GenomeWeb’s White Paper Channel. Job listings Senior Manager of Regulatory Affairs Company: DxTerity Location: Rancho Dominguez CA Apply now Research Associate II Company: SeraCare Life Sciences Location: Gaithersburg MD Apply now Manager, Reimbursement and Policy Company: Hologic Inc Location: San Diego CA Apply now Scientist I Company: SeraCare Life Sciences Location: Gaithersburg MD Apply now